Trademarkia Logo

Canada

C$
INRAYUS
REGISTERED

on 8 Mar 2023

Last Applicant/ Owned by

Sumitomo Pharma America, Inc.

84 Waterford DriveMarlborough MA 01752

US

Serial Number

2373826 filed on 19th May 2021

Registration Number

TMA1170314 registered on 8th Mar 2023

Registration expiry Date

19th May 2031

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300Toronto

ONTARIO

CA

M5E1G4

INRAYUS

Trademark usage description

pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating schizophrenia; pharmac Read More

Classification Information


Class [005]
Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating schizophrenia; pharmaceutical preparations for treating cognitive disorders.


Classification kind code

11

Mark Details


Serial Number

2373826

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 27
on 24th Nov 2022
Approval Notice Sent
Submitted for opposition 26
on 24th Nov 2022
Approved
Submitted for opposition 22
on 18th Nov 2022
Search Recorded
Submitted for opposition 48
on 22nd Jun 2022
Agent Changed
Submitted for opposition 256
on 6th Jun 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 5th Aug 2021
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 4th Aug 2021
Created
Submitted for opposition 31
on 4th Aug 2021
Formalized
Submitted for opposition 30
on 19th May 2021
Filed
Submitted for opposition 228
on 19th May 2021
International Registration